SK Bioscience Co Ltd (302440.KS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea · ISIN KR7302440003
SK Bioscience Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 267.55 bn KRW | 651.37 bn KRW |
| Gross profit | 30.98 bn KRW | 75.92 bn KRW |
| Operating income | -138.43 bn KRW | -123.50 bn KRW |
| EBIT | -85.42 bn KRW | -76.46 bn KRW |
| Net income | -53.88 bn KRW | -57.42 bn KRW |
| Diluted EPS – continuing operations | -701.32 KRW | -732.13 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SK Bioscience Co Ltd
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea. SK bioscience Co.,Ltd. is a subsidiary of SK Chemicals Co.,Ltd.
More stocks
- Gempharmatech Co. Ltd. A (688046.SS)
- VGP NV (VGP.BR)
- HANWHA IND SOL LTD (489790.KS)
- China Suntien Green Energy Corp Ltd (956.HK)
- Jiangnan Mould & Plastic Technology Co Ltd (000700.SZ)
- Emeis SA (EMEIS.PA)
- African Rainbow Minerals Ltd (ARI.JO)
- Tianjin Guangyu Development Co Ltd (000537.SZ)
- GETTY REALTY CORP /MD/ (GTY)
- Taiflex Scientific Co Ltd (8039.TW)
- Proto Labs Inc (PRLB)
- Silex Microsystems AB (SILEX.ST)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.